COVID-19: VACCINE AND DIAGNOSTIC TECHNOLOGIES
DM, PhD, DMS, professor
Republican Scientific and Practical Center
for Epidemiology and Microbiology,
220114 23 Filimonova str., Minsk, Belarus
The fact the SARS-CoV-2 coronavirus causes an unusual infection in the humans it have been described
before and will yet be analyzed by many virologists and clinicians in future. Much remains unclear with this
infection, for example: 1) why do older people get seriously ill, but children don’t; 2) will be effective the vaccine being developed by the traditional method, as it was with smallpox, polio, measles, etc., or not; 3) how the coronaviral biological features influence on the development and the using of monospecific genetic and serological diagnostic kits? This publication makes attempt to clear about the need to develop and acquire not ready vaccines and diagnostic kits, but the introduction of new non traditional technologies, because there are specific features related to biological features of the coronavirus, ecological factors or local biotopes for each region (climate zone, country, continent, etc.).
Keywords: SARS-CoV-2, COVID-19, CRISPR/Cas, AADH, vaccine, PCR, IgM and IgG-cross-reactivity, technologies.